Publications
Home / Antimicrobial resistance / The Use of eSwab® for CRE Screening and Surveillance in Clinical Microbiology

The Use of eSwab® for CRE Screening and Surveillance in Clinical Microbiology

Matteo Miriani, PhD, Senior Product & Marketing Manager

This white paper by Matteo Miriani highlights the effectiveness of the Copan eSwab® system for screening and surveillance of carbapenem‑resistant Enterobacterales (CRE). The study demonstrates that eSwab® ensures optimal microorganism recovery and stability, supporting both culture‑based and molecular CRE detection workflows. Its liquid Amies medium allows multiple downstream tests from a single rectal swab, improving laboratory efficiency and standardization. Results confirm that eSwab® enhances sensitivity, reproducibility, and workflow automation, making it a reliable solution for infection control programs and antimicrobial resistance surveillance in clinical microbiology laboratories.

Content reserved for premium users

Log in or register to access the full article

Share

LinkedInEmailWhatsApp